Valuation: Camurus AB

Market Cap 37.1B 3.83B 3.36B 3.13B 2.88B 5.39B 366B 5.48B 14.52B 181B 14.37B 14.06B 626B P/E 2026 *
39.1x
P/E 2027 * 25.2x
Enterprise Value 32.59B 3.36B 2.95B 2.75B 2.53B 4.74B 321B 4.82B 12.75B 159B 12.62B 12.35B 550B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.26x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-0.95%
Current month+10.52%
1 month+12.71%
3 months+18.15%
6 months-6.79%
Current year+1.46%
1 week 606
Extreme 606
631.5
1 month 525.5
Extreme 525.5
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2002
Director of Finance/CFO 57 30/06/2025
Chief Tech/Sci/R&D Officer 58 31/12/2024
Director TitleAgeSince
Director/Board Member 63 31/12/2001
Chairman 77 31/12/2014
Director/Board Member 61 06/05/2020
Date Insider Type Main position Quantity % Market Cap.
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

9,950 0.0166%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%-0.95%-11.91%+110.01% 3.83B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
-0.71%+10.17%+41.12%+35.33% 359B
-0.57%+3.81%+37.37%+42.88% 303B
+0.54%+2.54%+16.72%+16.43% 267B
-0.38%+4.71%-3.56%-38.74% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +1.19%+4.62%+28.02%+60.06% 373.5B
Weighted average by Cap. +1.36%+5.14%+40.75%+79.75%

Financials

2026 *2027 *
Net sales 2.85B 294M 258M 240M 221M 414M 28.05B 421M 1.11B 13.91B 1.1B 1.08B 48.07B 3.79B 391M 343M 320M 294M 551M 37.35B 560M 1.48B 18.52B 1.47B 1.44B 64B
Net income 925M 95.36M 83.68M 77.93M 71.67M 134M 9.11B 137M 362M 4.52B 358M 350M 15.61B 1.45B 150M 132M 122M 113M 211M 14.32B 215M 569M 7.1B 563M 551M 24.54B
Net Debt -4.52B -466M -409M -381M -350M -656M -44.51B -668M -1.77B -22.07B -1.75B -1.71B -76.27B -5.81B -599M -526M -489M -450M -844M -57.22B -858M -2.27B -28.38B -2.25B -2.2B -98.05B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
29/07/26 SEK 625.00 +0.24% 10,366
28/07/26 SEK 623.50 +1.14% 43,415
27/07/26 SEK 616.50 +0.08% 45,058
24/07/26 SEK 616.00 +0.16% 41,945
23/07/26 SEK 615.00 -2.54% 56,790
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
623.50SEK
Average target price
776.75SEK
Spread / Average Target
+24.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock